Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Brand Name :
Synonyms :
Class :
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
may decrease the levels of serum concentration of hormonal contraceptives
indinavir: they may increase serum concentrations of rifabutin
may diminish the concentration of serum when combined with indinavir
may diminish the concentration of serum when combined with indinavir
may diminish the concentration of serum when combined with indinavir
may diminish the concentration of serum when combined with indinavir
may diminish the concentration of serum when combined with indinavir
may diminish the serum concentration of Hormonal Contraceptives
It may enhance when combined with oxycodone by affecting CYP3A4 metabolism
indinavir: they may enhance the serum concentration of amiodarone
may enhance the serum concentration of CYP3A4 inhibitors
may enhance the serum concentration of CYP3A4 inhibitors
may enhance the serum concentration of CYP3A4 inhibitors
may enhance the serum concentration of CYP3A4 inhibitors
may enhance the serum concentration of CYP3A4 inhibitors
when both drugs are combined, the metabolism of paclitaxel decreases when compared with indinavir  
the effect of indinavir is increased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
CYP3A strong enhancers of the small intestine may reduce the bioavailability of indinavir
it increases the effect or level of ruxolitinib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
It may enhance the toxicity when combined with mipomersen
It may enhance the risk of adverse effects when combined with Protease inhibitors
has a synergistic effect over brentuximab vedotin, by showing altered intestinal/hepatic CYP3A4 enzyme metabolism.
when both drugs are combined, there may be an increased effect of abemaciclib by affecting hepatic or intestinal enzyme cyp3a4 metabolism  
indinavir increases the effect of gefitinib by altering the intestinal/ hepatic CYP3A4 enzyme metabolism
metronidazole enhances the effect of indinavir by altering the intestinal or hepatic CYP3A4 enzyme metabolism
may increase the serum concentration of Artemether and Lumefantrine
it increases by affecting the hepatic enzyme CYP3A4 metabolism
cyproterone and ethinyl estradiolÂ
may diminish the serum concentration when combined
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
tenofovir disoproxil fumarate or tenofovir DFÂ
monitoring of patients who develop TDF-associated adverse reactions in which tenofovir levels increase when taken along with HIV-1 protease inhibitors. If TDF-associated adverse reactions emerge, discontinue tenofovir DF in patients who develop them
the rate of metabolism of tocofersolan may be reduced with indinavir
indinavir, when taken with ixazomib, alters the intestinal/hepatic CYP3A4 enzyme metabolism
may increase the level by affecting the hepatic enzyme CYP3A4 metabolism